Related Experiment Video

Updated: Jan 31, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.6K

Nosocomial outbreak of multi-resistant Streptococcus pneumoniae serotype 15A in a centre for chronic pulmonary

Guido J H Bastiaens1, Amelieke J H Cremers1, Jordy P M Coolen1

  • 11Department of Medical Microbiology & Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.

Antimicrobial Resistance and Infection Control
|January 4, 2019
PubMed

Insights

Nosocomial transmission of multi-resistant serotype 15A Streptococcus pneumoniae (MRSP) caused two lower respiratory infections in a chronic pulmonary disease center. This highlights risks with vulnerable patients, long lab times, and poor adherence to precautions.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Hospital Epidemiology

Background:

  • Nosocomial transmission of multi-resistant serotype 15A Streptococcus pneumoniae (MRSP) identified.
  • Two cases of lower respiratory tract infections occurred in a chronic pulmonary disease center.

Discussion:

  • Outbreak highlights potential MRSP transmission among vulnerable patient populations.
  • Long laboratory turnaround times may facilitate pathogen spread.
  • Low patient compliance with transmission-based precautions is a significant risk factor.

Key Insights:

  • Serotype 15A Streptococcus pneumoniae poses a nosocomial threat.
  • Vulnerable patients in chronic care settings are at high risk.
  • Infection control breaches, including delayed diagnostics and poor adherence, amplify transmission.

Outlook:

  • Need for enhanced surveillance of multi-resistant Streptococcus pneumoniae in healthcare settings.
  • Importance of optimizing laboratory workflows to reduce turnaround times.
  • Strategies to improve patient education and compliance with infection control protocols are crucial.
Keywords:
Antimicrobial resistanceCross infectionNosocomialStreptococcus pneumoniaeWhole-genome sequencing

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.6K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.2K

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K